Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Pseudomonas aeruginosa Acquires Biofilm-Like Properties within Airway Epithelial Cells
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
One‐Year Incidence, Course, and Outcome Predictors of Frequent Headaches Among Early Adolescents
2005
Effectiveness and tolerability of high‐dose salmeterol in cystic fibrosis
2002
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
2011
Cetirizine
2004
Evolving concepts in biofilm infections
2009 Standout
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
2006 Standout
The epidemiology of chronic pain in children and adolescents revisited: A systematic review
2011 Standout
Pharmacotherapy of impaired mucociliary clearance in non‐CF pediatric lung disease. A review of the literature
2007
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
2003
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
The cytokine storm of severe influenza and development of immunomodulatory therapy
2015 Standout
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium
2000
Development and first validation of the COPD Assessment Test
2009 Standout
Interpretative strategies for lung function tests
2005 Standout
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Review of Macrolides and Ketolides
2001
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
2011
Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators
2007
Airway Mucus Function and Dysfunction
2010 Standout
One‐Year Follow‐Up of Headache in an Adult General Population
2005
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
1999
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Cardiovascular Safety of Salmeterol in COPDa
2003
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
2001
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
2007 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway
1999 StandoutNobel
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
2004
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Cumulative Lifetime Migraine Incidence in Women and Men
2008
Rapid ‘SAR’ via Click Chemistry: An Alkyne-Bearing Spiramycin is fused with Diverse Azides to Yield New Triazole-Antibacterial Candidates
2006 StandoutNobel
Migraine Headaches in Adolescents: A Student Population-Based Study in Monreale
1995
Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia
2011
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Age-related alterations in potentiation in the CA1 region in F344 rats
1993
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Macrolide Antibacterials
1995
Works of G Santangelo being referenced
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study
1995
Impact of Rokitamycin, a New 16-Membered Macrolide, on Serum Theophylline
1991
Pulmonary Penetration of Ceftazidime
1995
Migraine Headaches in Adolescents: A Five‐Year Follow‐Up Study
2002
A Five-Day Course of Dirithromycin in the Treatment of Acute Exacerbation of Severe Chronic Obstructive Pulmonary Disease
1997
Effect of Salmeterol and Formoterol in Patients with Chronic Obstructive Pulmonary Disease
1994
Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment.
2002
A combination of cefuroxime and N-acetyl-cysteine for the treatment of lower respiratory tract infections in children.
1985
Migraine Headaches in a High School Student Population.
1991
An in vitro study of the possible interaction between human platelets and cephalosporins.
1991
Serum Tryptase in Allergic Rhinitis: Effect of Cetirizine Treatment
2001
Cetirizine, a Second-Generation H1 Antagonist, Modulates Rantes and MCP-1 Levels in Allergic Rhinitis
2002